共 87 条
- [1] Bouhuys M., Lexmond W.S., Van Rheenen P.F., Pediatric inflammatory bowel disease, Pediatrics, 151, (2023)
- [2] Agrawal M., Sabino J., Frias-Gomes C., Hillenbrand C.M., Soudant C., Axelrad J.E., Et al., Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses, EClinicalMedicine, 36, (2021)
- [3] Wu S., Yi J., Wu B., Casual associations of thyroid function with inflammatory bowel disease and the mediating role of cytokines, Front Endocrinol (Lausanne), 15, (2024)
- [4] Bandgar T.R., Shah N.S., Thyroid disorders in childhood and adolescence, J Indian Med Assoc, 104, (2006)
- [5] Biancone L., Armuzzi A., Scribano M.L., Castiglione F., D'inca R., Orlando A., Et al., Cancer risk in inflammatory bowel disease: A 6-year prospective multicenter nested case–control IG-IBD study, Inflamm Bowel Dis, 26, 3, (2020)
- [6] Beaugerie L., Itzkowitz S.H., Cancers complicating inflammatory bowel disease, N Engl J Med, 372, (2015)
- [7] Lutgens M.W.M.D., van Oijen M.G.H., van der Heijden G.J.M.G., Vleggaar F.P., Siersema P.D., Oldenburg B., Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies, Inflammation Bowel Dis, 19, (2013)
- [8] Scharl S., Barthel C., Rossel J.B., Biedermann L., Misselwitz B., Schoepfer A.M., Et al., Malignancies in inflammatory bowel disease: frequency, incidence and risk factors-results from the Swiss IBD cohort study, Am J Gastroenterol, 114, (2019)
- [9] Faye A.S., Holmer A.K., Axelrad J.E., Cancer in inflammatory bowel disease, Gastroenterol Clin North Am, 51, (2022)
- [10] Zhang H., Shi Y., Lin C., He C., Wang S., Li Q., Et al., Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota, Front Immunol, 14, (2023)